Summary: InStyle speaks with Corine de Boer, M.D., Ph.D., of MAPS Public Benefit Corporation (MAPS PBC), Natalie Lyla Ginsberg, M.S.W., of MAPS, and a past MAPS-sponsored clinical trial participant about MDMA-assisted therapy for the treatment of PTSD.
Read the article to learn about MAPS’ clinical trials involving MDMA-assisted therapy, the personal experience of the study participant, and the implications of a potential future in which MDMA-assisted therapy is a legal and accessible treatment option for individuals with PTSD.
